ADC Therapeutics (ADCT) is down -4.5%, or -16c to $3.43.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADCT:
- Biotech Alert: Searches spiking for these stocks today
- ADC Therapeutics’ Earnings Call: Clinical Wins Amid Challenges
- ADC Therapeutics Reports Q1 2025 Financial Results
- ADC announces data presentation from LOTIS-7 Phase 1b clinical trial
- ADC Therapeutics presents positive efficacy data from three ADCs at AACR 2025